In prostate cancer, sCLU affects the nuclear translocation and activity of NF-κB; silencing of sCLU stabilizes IκB and reduces NF-κB gene transcription (Zoubeidi et al., 2010[194]). The gene discussed is NFKB1; the disease is Familial prostate cancer.